cytarabine has been researched along with tolbutamide in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Giaume, C; Jiménez, C; Medina, JM; Tabernero, A; Velasco, A | 1 |
Bunte, M; Dringen, R; Ehrenreich, H; Giaume, C; Hasselblatt, M; Medina, JM; Sirén, AL; Tabernero, A | 1 |
1 review(s) available for cytarabine and tolbutamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for cytarabine and tolbutamide
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The enhancement of glucose uptake caused by the collapse of gap junction communication is due to an increase in astrocyte proliferation.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Arachidonic Acid; Astrocytes; Biological Transport; Cell Communication; Cell Division; Cells, Cultured; Culture Media, Serum-Free; Cytarabine; Cytochalasin B; Dehydroepiandrosterone; Endothelin-1; Enzyme Inhibitors; Gap Junctions; Glucose; Glycyrrhetinic Acid; Hypoglycemic Agents; Ouabain; Pentose Phosphate Pathway; Rats; Rats, Wistar; Ribosemonophosphates; Tolbutamide | 2001 |
Effect of endothelin-1 on astrocytic protein content.
Topics: Animals; Antimetabolites; Antimetabolites, Antineoplastic; Astrocytes; Bromodeoxyuridine; Cells, Cultured; Cycloheximide; Cytarabine; Endothelin Receptor Antagonists; Endothelin-1; Gap Junctions; Hypoglycemic Agents; Nerve Tissue Proteins; Propionates; Protein Synthesis Inhibitors; Pyrimidines; Rats; Rats, Mutant Strains; Rats, Wistar; Receptors, Endothelin; Tolbutamide | 2003 |